Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study

被引:7
|
作者
Ashraf Alzaabi
Nasser Al Busaidi
Rohit Pradhan
Fathelrahman Shandy
Naseem Ibrahim
Moulham Ashtar
Khaled Khudadah
Khaled Hegazy
Mohamed Samir
Mohamed Negm
Hisham Farouk
Arwa Al Khalidi
Maarten Beekman
机构
[1] Zayed Military Hospital,Pulmonology Department
[2] Royal Hospital,Pulmonology Medicine Department
[3] Rashid Hospital,Pulmonology Medicine Department
[4] Dubai Health Authority,Primary Health Care Department
[5] Emirates Health Services Establishment,Health Affairs Department
[6] Primary Health Care Services Sector,Department of Family Medicine
[7] Dubai Health Authority,Medical Affairs Department
[8] Ahmadi Hospital,undefined
[9] Sabah El-Salem Primary Healthcare Centre,undefined
[10] Al-Rumaithiya Primary Healthcare Centre,undefined
[11] Al Adan Hospital,undefined
[12] AstraZeneca,undefined
[13] AstraZeneca,undefined
关键词
Asthma; Exacerbations; Gulf region; Over-prescription; SABINA; Short-acting β; -agonists;
D O I
10.1186/s40733-022-00085-5
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Over-prescription of short-acting beta agonists in the treatment of asthma
    Looijmans-van den Akker, Ingrid
    Werkhoven, Anouk
    Verheij, Theo
    [J]. FAMILY PRACTICE, 2021, 38 (05) : 612 - 616
  • [2] Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study
    Modi, Mahavir
    Mody, Kavita
    Jhawar, Pramod
    Sharma, Lata
    Anand, Mahesh Padukudru
    Gowda, Giriyanna
    Mendiratta, Manisha
    Kumar, Sudhir
    Nayar, Sandeep
    Manchanda, Manav
    Kumari Badam, Aruna
    Singh, Manoj
    Siddiqui, Waseem
    Beekman, Maarten
    [J]. JOURNAL OF ASTHMA, 2023, 60 (07) : 1347 - 1358
  • [3] Short-acting ß2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.
    Sarma, Latha
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINAIII study
    Khattab, Adel
    Madkour, Ashraf
    Ambaram, Anish
    Smith, Clifford
    Muhwa, Chakaya J.
    Mecha, Jared O.
    Alsayed, Mohamed
    Beekman, Maarten J. H., I
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1983 - 1995
  • [5] Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study
    Montero-Arias, Felicia
    Herrera Garcia, Jose Carlos
    Pacheco Gallego, Manuel
    Anton Antila, Martti
    Schonffeldt, Patricia
    Javier Mattarucco, Walter
    Tejado Gallegos, Luis Fernando
    Beekman, Maarten J. H., I
    [J]. JOURNAL OF ASTHMA, 2023, 60 (03) : 574 - 587
  • [6] Over-prescription of short-acting β2-agonists remains a serious health concern in Kenya: results from the SABINA III study
    Chakaya, Jeremiah
    Mecha, Jared
    Beekman, Maarten
    [J]. BMC PRIMARY CARE, 2023, 24 (01):
  • [7] Over-prescription of short-acting β2-agonists remains a serious health concern in Kenya: results from the SABINA III study
    Jeremiah Chakaya
    Jared Mecha
    Maarten Beekman
    [J]. BMC Primary Care, 24
  • [8] Prescription behaviour of short-acting β2-agonists in Switzerland
    Schuoler, Claudio
    Steurer-Stey, Claudia
    Ullmer, Elke
    Providoli, Romeo
    Chicherov, Vitaly
    Korobeynikova, Maria
    Wetzel, Stefan
    Pendl, Gunther
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] Paradoxical asthma hazard of short-acting β2-agonists
    Seed, M. J.
    Agius, R. M.
    [J]. ALLERGY, 2008, 63 (02) : 241 - 241